Healthpeak Properties (DOC) to Release Quarterly Earnings on Tuesday

Posted by Brenda Bartman on Jul 28th, 2026

Healthpeak Properties (NYSE:DOC – Get Free Report) is projected to release its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect the company to post earnings of $0.0282 per share and revenue of $725.6440 million for the quarter. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Investors are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 10:00 AM ET.

Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the business earned $0.46 EPS. On average, analysts expect Healthpeak Properties to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Healthpeak Properties Stock Up 0.6%

Shares of Healthpeak Properties stock traded up $0.14 during trading on Tuesday, hitting $22.66. 475,189 shares of the stock were exchanged, compared to its average volume of 8,672,786. The stock has a market cap of $15.62 billion, a price-to-earnings ratio of 70.88, a price-to-earnings-growth ratio of 3.46 and a beta of 1.02. The firm’s 50-day moving average price is $20.80 and its 200 day moving average price is $18.51. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $22.77. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a yield of 5.4%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio is 381.25%.

Insider Activity at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

A number of large investors have recently made changes to their positions in the stock. Advocate Investing Services LLC purchased a new stake in Healthpeak Properties during the fourth quarter worth about $26,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Healthpeak Properties during the 2nd quarter valued at approximately $33,000. DV Equities LLC purchased a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $36,000. Wiser Advisor Group LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $38,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Healthpeak Properties in the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on DOC. UBS Group upped their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Raymond James Financial initiated coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating on the stock. Barclays began coverage on Healthpeak Properties in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 target price for the company. Morgan Stanley reiterated an “equal weight” rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Finally, Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Four investment analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and a consensus target price of $20.62.

View Our Latest Research Report on Healthpeak Properties

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.